1380331-13-4

Upstream product

• 36016-40-7 mesitylenesulfonylhydroxylamine 
• 1202704-61-7 1,2-diamino-4-bromopyridin-1-ium-2,4,6-trimethylbenzenesulfonate 
• 4248-19-5 tert-butyl carbazate 
• 1380331-12-3 7-bromo-2-phenyl-[1,2,4]triazolo[1,5-a]pyridine 
• 84249-14-9 2-amino-4-bromopyridine 

Downstream Products

• 1380330-74-4 2-methyl-2H-pyrazole-3,4-dicarboxylic acid 4-[(2-fluoro-ethyl)-amide] 3-[(2-phenyl[1,2,4]triazolo[1,5-a]pyridin-7-yl)-amide] 
• 1380330-70-0 2-methyl-2H-pyrazole-3,4-dicarboxylic acid 4-[(2-hydroxy-ethyl)-methyl-amide] 3-[(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-amide] 
• 1380330-24-4 2-methyl-2H-pyrazole-3,4-dicarboxylic acid 4-(cyclopropyl-methyl-amide) 3-[(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-amide] 
• 1380329-98-5 N₄,1-dimethyl-N-5-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-4,5-dicarboxamide 
• 1380329-95-2 N₄,1-dimethyl-N-4-(((6-methyl)pyridin-3-yl)methyl)-N-5-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-4,5-dicarboxamide 
• 1380329-94-1 N₄-isopropyl-1-methyl-N-5-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-4,5-dicarboxamide 
• 1380329-93-0 N₄,N₄-diethyl-1-methyl-N-5-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-4,5-dicarboxamide 
• 1380329-92-9 1-methyl-N₄-(oxetan-3-yl)-N-5-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-4,5-dicarboxamide 
• 1380329-91-8 N₄-(3-methoxypropyl)-1-methyl-N-5-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-4,5-dicarboxamide 
• 1380329-90-7 (R)-1-methyl-N-5-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N₄-(tetrahydrofuran-3-yl)-1H-pyrazole-4,5-dicarboxamide 
• 1380329-89-4 (S)-1-methyl-N-5-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N₄-(tetrahydrofuran-3-yl)-1H-pyrazole-4,5-dicarboxamide 
• 1380329-86-1 2-methyl-2H-pyrazole-3,4-dicarboxylic acid 4-dimethylamide 3-[(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)amide] 
• 1380329-81-6 N₄,N₄-bis(2-methoxyethyl)-1-methyl-N-5-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-1H-pyrazole-4,5-dicarboxamide 
• 1380329-79-2 2-methyl-2H-pyrazole-3,4-dicarboxylic acid 4-[(2-methoxy-ethyl)-methyl-amide]3-[(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-amide] 

Relevant academic research and scientific papers

USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF TOURETTE SYNDROME

Provided herein are methods of treating Tourette Syndrome in a subject in need thereof by administering to the subject compositions comprising a PDE10 inhibitor of Formula (I). Also disclosed are crystalline solid forms of the compound of Formula (I) and

NOVEL PYRAZOLE DERIVATIVE

It has been desired to develop a pharmaceutical composition, which is used in agents for preventing and/or treating various diseases related to PDE10 (e.g. mental disorder and neurodegenerative disorder). The present invention provides: compounds having PDE10 inhibitory effect, in particular, compounds having a 4-heteroarylpyrazole-5-carboxylic acid amide structure represented by the following formula (I), or their pharmaceutically acceptable salts, or their solvates; pharmaceutical compositions comprising, as active ingredients, the compounds, or their pharmaceutically acceptable salts, or their solvates; and medical use of the compounds, or their pharmaceutically acceptable salts, or their solvates.

TRIAZOLOPYRIDINE COMPOUNDS

The invention is concerned with triazolopyridine compounds of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These

TRIAZOLOPYRIDINE COMPOUNDS

The invention is concerned with triazolopyridine compounds of formula (I), wherein R1, R2 , R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. The